Identification and characterization of E2A-PBX1 genomic binding sites using ChIP-seq and bioinformatics
Loading...
Authors
Nanan, Kyster
Date
2014-07-16
Type
thesis
Language
eng
Keyword
Bioinformatics , Cancer Biology , Epigenetics , Next-Generation Sequencing , Leukemia , Transcription Factors
Alternative Title
Abstract
A translocation between chromosomes 1 and 19, referred to as t(1;19), results in expression of the chimeric, oncogenic transcription factor E2A-PBX1 in cases of B-progenitor acute lymphoblastic leukemia. Previous studies have shown that E2A-PBX1 functions as an activator of target gene transcription and that oncogenesis requires direct binding of E2A-PBX1 with the histone acetyltransferase CBP/p300. However, the transcriptional targets of this complex remain largely unknown. To identify and characterize genomic sites bound by E2A-PBX1 we performed RNA-seq and ChIP-seq for E2A-PBX1, p300 and the functional histone marks H3K4me1, H3K4me3, and H3K27me3 in the t(1;19) leukemic cell line RCH-ACV. Putative E2A-PBX1 binding sites were validated by site-specific ChIP-qPCR. Bioinformatics tools were used to perform “integrative analysis” and characterize E2A-PBX1 binding on a genome-wide scale.
This analysis resulted in the identification of 555 high-confidence E2A-PBX1 sites in the RCH-ACV genome most of which occur distally (>10kb) relative to the TSSs of known genes. Ontology and pathway analysis showed that candidate E2A-PBX1 target genes are involved in hematopoiesis, lymphopoiesis, and cancer progression. Binding of E2A-PBX1 to a random sampling of these sites was performed using site-specific ChIP-qPCR. Consistent with earlier results, E2A-PBX1-bound sites were strongly associated with p300 recruitment and the activating chromatin marks H3K4me1 and H3K4me3; analysis of RNA-seq data confirmed a strong association between proximate binding by E2A-PBX1 and gene transcription. Surprisingly, rather than associating with consensus PBX1 binding sequences as expected, E2A-PBX1 associated with sites bound by the B-lymphopoietic transcription factors EBF1 and wild-type E2A; EBF1, E2A and E2A-PBX1 were confirmed to co-localize at selected E2A-PBX1 binding sites. The results of this study identify hundreds of E2A-PBX1 genomic binding sites, confirm CBP/p300 recruitment and transcriptional activation in association with these sites, and raise the novel and surprising possibility that E2A-PBX1 disrupts the transcriptional regulation of B-lymphopoiesis through physically associating with the lymphopoietic transcription factors EBF1 and wild-type E2A.
Description
Thesis (Ph.D, Pathology & Molecular Medicine) -- Queen's University, 2014-07-16 12:24:55.279
Citation
Publisher
License
This publication is made available by the authority of the copyright owner solely for the purpose of private study and research and may not be copied or reproduced except as permitted by the copyright laws without written authority from the copyright owner.